secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001193125-24-272464
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics stockholders approve reverse stock split proposal at ratios up to 1-for-15
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split proposal at special meeting on December 3, 2024.
- Ratio range: 1-for-2 to 1-for-15, inclusive, with board to set final ratio in its discretion.
- Vote results: 12,723,707 for, 9,810,591 against, 415,687 abstentions.
- On December 5, 2024, entered Amendment No. 2 to Rights Agreement for technical board administration changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/0001193125-24-272464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/d899818d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-272464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer